Tecan and laboratory software specialist UgenTec have announced a collaboration to develop fully integrated, sample-to-result solutions for PCR workflows. This newly formed partnership will combine Tecan’s liquid handling and automation expertise with UgenTec’s best-in-classFastFinder software, integrating end-to-end automation with comprehensive data analysis and workflow tools, providing high throughput solutions for molecular testing.

The COVID-19 pandemic has highlighted the challenges associated with high throughput molecular testing, requiring a more integrated approach to meet workload demands without compromising on the quality of results. Tecan and UgenTec will overcome this issue bycreating a fully automated workflow – from sample preparation to data analysis and interpretation – using Tecan’s automation workstations with UgenTec’s FastFinder software suite. The joint solutions will be offered directly to diagnostics labs globally, as well as forming the basis of OEM in vitro diagnostics platforms developed through Tecan Synergence™.

Ralf Griebel, Head of Partnering Business at Tecan, commented: “This partnership with UgenTec is another important milestone in our growing digital ecosystem. We strongly believe that open innovation is the best way to provide labs with powerful solutions to meet the challenges they face today, and to better prepare them for the future, and UgenTec’s forward-thinking approach and leading position in molecular diagnostics made the company a natural fit.” 

Michiel Reessink, VP of Global Sales at UgenTec, added: “Efficient automation is now essential for molecular diagnostics labs to attain the throughput and traceability necessary to meet international quality and compliance standards. The combination of our diagnostics-oriented artificial intelligence tools with Tecan’s market-leading liquid handling technologies provides the perfect end-to-end solution, helping labs to achieve the accuracy and scalability required to address current and future challenges in molecular diagnostics.”

To learn more about the Tecan’s offering in Genomics, visit diagnostics.tecan.com/molecular-genetics  

About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company hasmanufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2019, Tecan generated sales of CHF 637 million (USD 643 million; EUR 574 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).

Über Tecan

Tecan (www.tecan.com) ist ein weltweit führender Anbieter von Laborinstrumenten und Lösungen für die Branchen Biopharma, Forensik und Klinische Diagnostik. Das Unternehmen ist auf Entwicklung, Herstellung und Vertrieb von Automatisierungslösungen für Laboratorien im Life-Science-Bereich spezialisiert. Die Kunden von Tecan sind Pharma- und Biotechnologieunternehmen, Forschungs-abteilungen von Universitäten sowie forensische und diagnostische Laboratorien. Als Originalgeräte-hersteller (OEM) ist Tecan auch führend in der Entwicklung und Herstellung von OEM-Instrumenten und Komponenten, die vom jeweiligen Partnerunternehmen vertrieben werden. Tecan wurde 1980 in der Schweiz gegründet. Das Unternehmen verfügt über Produktions-, Forschungs- und Entwicklungs-stätten in Europa und in Nordamerika. In 52 Ländern unterhält es ein Vertriebs- und Servicenetz. Im Jahr 2019 erzielte Tecan einen Umsatz von CHF 637 Mio. (USD 643 Mio.; EUR 574 Mio.). Die Namenaktien der Tecan Group werden an der SIX Swiss Exchange gehandelt (TECN; ISIN CH0012100191).

About UgenTec

UgenTec (www.ugentec.com) is a leading molecular laboratory software provider servicing molecular diagnostics labs and assay providers globally across clinical, animal and agbio applications. Its FastFinder software platform is a modular, clinical-grade Software-as-a-Service solution that allows labs of all sizes to standardize and automate their molecular testing workflows. UgenTec’s FastFinder platform applies Artificial Intelligence to automate data analysis from sample to result, track and trace samples across the entire assay menu and instrument fleet, and provide the lab with valuable real-time insights in quality and lab operations. FastFinder’s modules include Workflow, Analysis, Insights and Workflow.